Another Xarelto Lawsuit Filed in The Philadelphia County

Another Xarelto Lawsuit Filed in The Philadelphia County

Introduction

Mid-April, Philadelphia County will witness the beginning of the second Xarelto linked gastrointestinal bleeding lawsuit. The defendants named in this litigation, Bayer Healthcare Pharmaceuticals Inc. and J&J subsidiary Janssen Pharmaceuticals Inc., are relying heavily on the deposition testimonies made by two of the plaintiff’s doctors, who prescribed Xarelto to reduce the plaintiff’s risk of stroke. According to the testimony, the doctors were well aware of bleeding risks and stated that an additional warning regarding the risk of bleeding would not have changed their prescribing decisions.

In January, Common Pleas Judge Michael Erdos rejected a $28 million verdict awarded to the plaintiff based on the statements made by the prescribing doctor that she had known about the risks of the drug and would have prescribed it anyway even if stronger warnings had been provided. This was also the first of more than 1,700 Philadelphia County Xarelto Lawsuits to go before trial.

Xarelto lawsuits are centralized in the U.S. District Court for the Eastern District of Louisiana before Judge Eldon E. Fallon as a part of MDL- 2592 Xarelto Products Liability Litigation. Currently, more than 22,000 Xarelto cases are pending in several courts across the country.